tykhr
sign in
free sign up
Rigel Pharmaceuticals Inc
Biotechnology
Healthcare
RIGL
18.16 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
34.45
52 week high
41.99
high
35.30
52 week low
0.00
low
33.90
growth
147.24 %
previous Close
34.45
P/E ratio
10
market cap
544 M
div yield
0
usd
Jun 2025
qoq
revenue
102 M
90.66 %
net incoming
59.61 M
420.82 %
eps
3.28 %
420.63 %
eps surprise
133.45 %
net profit margin
58.63 %
37.00 %
operating incoming
61.10 M
378.38 %
net change in cash
7.68 M
170.06 %
cash on hand
53.41 M
16.79 %
cost of revenue
4.50 M
2.15 %
top